The new magnetic resonance imaging (MRI) device reportedly offers deep learning technologies and advanced processing of whole-body images in a cost-effective and lightweight model.
An emerging whole body magnetic resonance imaging (MRI) system may provide enhanced imaging capabilities with lower costs and energy consumption in comparison to conventional whole body MRI scanners.
The MAGNETOM Free.Star MRI scanner, recently cleared by the Food and Drug Administration (FDA), offers targeted denoising and high-resolution scans through artificial intelligence (AI)-powered Deep Resolve algorithms, according to Siemens Healthineers, the manufacturer of the MRI system.
Noting that the MAGNETOM Free.Star device is the smallest and most lightweight whole-body MRI system it has manufactured, the company emphasized that it requires less than one liter of liquid helium and no quench pipe. Siemens Healthineers said the reduced energy consumption can lead to a greater than 30 percent reduction in lifecycle costs of the device in comparison to other MRI devices.
Siemens Healthineers noted another aspect of the modality is the myExam Companion, which enhances exam efficiency through AI.
“The MAGNETOM Free.Star is further proof of our steadfast commitment to providing customers with MRI scanners that are more cost-effective, more easily operable, and more easily sited for installation at a wide variety of healthcare institutions across the United States,” noted Jane Kilkenny, the vice president of MR Business Management at Siemens Healthineers.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.